Vertex Pharmaceuticals
Price & Volume
Stats
See more52W Range | $377.85-$519.88 |
Market Cap | $124.3B |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $11B |
Revenue Growth (YoY) | 15.7% |
Gross Profit (12 Mos) | $9.4B |
Diluted EPS | -$2.08 |
News
See moreYahoo Finance • 10 days ago
Vertex Pharmaceuticals price target raised to $450 from $433 at Scotiabank
Yahoo Finance • 10 days ago
Vertex Pharmaceuticals price target raised to $520 from $460 at Truist
Yahoo Finance • 11 days ago
Vertex Pharmaceuticals Inc (VRTX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Yahoo Finance • 13 days ago
2 Biotech Stocks to Buy Hand Over Fist in February
About
CEO | Dr. Reshma Kewalramani FASN, M.D. |
CFO | Mr. Charles F. Wagner Jr. |
Address | 50 Northern Avenue, Boston, MA, United States, 02210 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 6,100 |
